Royalty Pharma plc

RPRX

$44.80

Name : Royalty Pharma plc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $25,912,731,648.00

EPSttm : 1.78

Royalty Pharma plc

$44.80

1.21%

$0.535

Float Short %

6.81

Margin Of Safety %

Put/Call OI Ratio

0.48

EPS Next Q Diff

-0.02

EPS Last/This Y

2.72

EPS This/Next Y

0.44

Price

44.81

Target Price

51.43

Analyst Recom

1.42

Performance Q

14.99

Relative Volume

1.43

Beta

0.41

Ticker: RPRX

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-01-14	RPRX	40.21	0.46	0.06	10043
2026-01-15	RPRX	39.72	0.46	0.13	10081
2026-01-16	RPRX	39.54	0.46	0.06	10096
2026-01-20	RPRX	39.04	0.70	0.19	7120
2026-01-21	RPRX	39.72	0.69	0.46	7219
2026-01-22	RPRX	40.1	0.66	6.01	7754
2026-01-23	RPRX	40.4	0.74	0.14	8780
2026-01-26	RPRX	40.47	0.68	0.02	9399
2026-01-27	RPRX	40.72	0.68	0.01	9471
2026-01-28	RPRX	40.41	0.67	58.13	9531
2026-01-29	RPRX	40.85	0.70	6.28	9744
2026-01-30	RPRX	41.67	0.83	1.70	10369
2026-02-02	RPRX	42.35	0.78	0.01	10217
2026-02-03	RPRX	42.96	0.78	0.00	10246
2026-02-05	RPRX	43.85	0.61	0.01	11785
2026-02-09	RPRX	44.06	0.52	0.05	13120
2026-02-10	RPRX	44.23	0.52	1.11	13147
2026-02-11	RPRX	44.26	0.52	0.07	13310
2026-02-12	RPRX	44.82	0.48	0.00	14000
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-01-14	RPRX	40.22	13.9	749.2	4.64
2026-01-15	RPRX	39.72	13.9	734.8	4.64
2026-01-16	RPRX	39.55	13.9	747.7	4.64
2026-01-20	RPRX	39.03	16.5	733.3	4.64
2026-01-21	RPRX	39.71	16.5	781.1	4.64
2026-01-22	RPRX	40.12	16.5	771.1	4.64
2026-01-23	RPRX	40.40	16.5	766.7	4.64
2026-01-26	RPRX	40.52	16.5	759.6	4.64
2026-01-27	RPRX	40.71	16.5	764.5	4.64
2026-01-28	RPRX	40.42	16.5	741.5	4.64
2026-01-29	RPRX	40.85	15.6	773.0	4.64
2026-01-30	RPRX	41.67	15.6	787.6	4.64
2026-02-02	RPRX	42.34	15.6	781.1	4.64
2026-02-03	RPRX	42.96	15.8	778.5	4.64
2026-02-04	RPRX	43.69	15.8	782.7	4.64
2026-02-05	RPRX	44.10	15.8	771.0	4.64
2026-02-06	RPRX	44.65	15.8	775.8	4.64
2026-02-09	RPRX	44.06	15.8	732.2	4.64
2026-02-10	RPRX	44.24	15.8	761.8	4.64
2026-02-11	RPRX	44.27	15.8	756.5	4.64
2026-02-12	RPRX	44.81	15.8	776.2	4.64
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-01-14	RPRX	-0.74	-2.20	8.56
2026-01-15	RPRX	-0.74	-2.20	8.56
2026-01-16	RPRX	-0.74	-2.20	8.56
2026-01-20	RPRX	-0.74	-2.25	8.56
2026-01-21	RPRX	-0.76	-2.25	8.56
2026-01-22	RPRX	-0.76	-2.25	8.56
2026-01-23	RPRX	-0.76	-2.25	8.56
2026-01-26	RPRX	-0.83	-2.27	8.56
2026-01-27	RPRX	-0.83	-2.27	8.56
2026-01-28	RPRX	-0.83	-2.27	8.18
2026-01-29	RPRX	-0.83	-2.27	8.18
2026-01-30	RPRX	-0.83	-2.27	8.18
2026-02-02	RPRX	-0.83	-2.39	8.17
2026-02-03	RPRX	-0.85	-2.39	8.17
2026-02-04	RPRX	-1.05	-2.39	8.17
2026-02-05	RPRX	-1.05	-2.39	8.17
2026-02-06	RPRX	-1.05	-2.39	8.17
2026-02-09	RPRX	-1.05	3.19	7.08
2026-02-10	RPRX	-2.43	3.19	7.08
2026-02-11	RPRX	-2.43	3.19	6.81
2026-02-12	RPRX	-2.37	3.19	6.81
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

1.17

Avg. EPS Est. Current Quarter

1.31

Avg. EPS Est. Next Quarter

1.15

Insider Transactions

-2.37

Institutional Transactions

3.19

Beta

0.41

Average Sales Estimate Current Quarter

839

Average Sales Estimate Next Quarter

859

Fair Value

52.46

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

8.2

Max Drawdown 5-Year %

-45.5

Target Price

51.43

P/E

25.16

Forward P/E

8.55

PEG

1.15

P/S

10.87

P/B

2.97

P/Free Cash Flow

9.97

EPS

1.78

Average EPS Est. Cur. Y

4.64

EPS Next Y. (Est.)

5.08

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

32.41

Relative Volume

1.43

Return on Equity vs Sector %

-15.9

Return on Equity vs Industry %

0.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

776.2

Royalty Pharma plc

Sector: Healthcare

Industry: Biotechnology

Employees: 100

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

stock quote shares RPRX – Royalty Pharma plc Stock Price stock today

news today RPRX – Royalty Pharma plc stock forecast ,stock prediction 2023 2024 2025

marketwatch RPRX – Royalty Pharma plc yahoo finance google finance

stock history RPRX – Royalty Pharma plc invest stock market

stock prices RPRX premarket after hours

ticker RPRX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: RPRX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y